Dr. Annette M. Moore

Claim this profile

Community Cancer Center South

Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
2 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
Community Cancer Center South
Image of trial facility.
Community Cancer Center East

Clinical Trials Annette M. Moore is currently running

Image of trial facility.

Lenalidomide +/- Daratumumab

for Multiple Myeloma

Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first randomization). Patients are randomized between Lenalidomide for 2 years and Lenalidomide + Daratumumab/rHuPH20. After 2 years of Maintenance, MRD is assessed to guide further therapy. MRD-positive patients will continue with the assigned treatment. MRD-negative patients will be further randomized (Reg Step 3) to either continue or discontinue the assigned treatment. Patients are treated for up to 7 years from Step 2 reg and followed for up to 15 years.
Recruiting2 awards Phase 317 criteria

More about Annette M. Moore

Clinical Trial Related6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Annette M. Moore has experience with
  • Daratumumab/rHuPH20
  • Lenalidomide
  • Cetuximab
  • Irinotecan Hydrochloride
  • Pertuzumab
  • Trastuzumab
Breakdown of trials Annette M. Moore has run
Multiple Myeloma
Plasma Cell Neoplasms
Adenocarcinoma
HER2 Gene Amplification
Cancer

Other Doctors you might be interested in

Bert H O'Neil, MDIndiana University Melvin and Bren Simon Cancer Center
Natraj R AmmakkanavarCommunity Health Network
Daniel W. WeedCommunity Health Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Annette M. Moore specialize in?
Annette M. Moore focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Annette M. Moore currently recruiting for clinical trials?
Yes, Annette M. Moore is currently recruiting for 1 clinical trial in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Annette M. Moore has studied deeply?
Yes, Annette M. Moore has studied treatments such as Daratumumab/rHuPH20, Lenalidomide, Cetuximab.
What is the best way to schedule an appointment with Annette M. Moore?
Apply for one of the trials that Annette M. Moore is conducting.
What is the office address of Annette M. Moore?
The office of Annette M. Moore is located at: Community Cancer Center South, Indianapolis, Indiana 46227 United States. This is the address for their practice at the Community Cancer Center South.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top